FR901464 50mg 50mg | Purity Not Available
Adooq Bioscience
FR901464 is a potent anticancer natural product that lowers the mRNA levels of oncogenes and tumor suppressor genes.
More Information Supplier PageSearch Results
FR901464 5mg 5mg | Purity Not Available
Adooq Bioscience
FR901464 is a potent anticancer natural product that lowers the mRNA levels of oncogenes and tumor suppressor genes.
More Information Supplier PageFR901464 25mg 25mg | Purity Not Available
Adooq Bioscience
FR901464 is a potent anticancer natural product that lowers the mRNA levels of oncogenes and tumor suppressor genes.
More Information Supplier PageFR901464 10mg 10mg | Purity Not Available
Adooq Bioscience
FR901464 is a potent anticancer natural product that lowers the mRNA levels of oncogenes and tumor suppressor genes.
More Information Supplier PagePacritinib (SB1518) 25mg 25mg | Purity Not Available
Adooq Bioscience
Pacritinib, also known as SB1518, is an orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Pacritinib competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and so caspase-dependent apoptosis.
More Information Supplier PagePacritinib (SB1518) 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
Pacritinib, also known as SB1518, is an orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Pacritinib competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and so caspase-dependent apoptosis.
More Information Supplier PagePacritinib (SB1518) 10mg 10mg | Purity Not Available
Adooq Bioscience
Pacritinib, also known as SB1518, is an orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Pacritinib competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and so caspase-dependent apoptosis.
More Information Supplier PagePalifosfamide 50mg 50mg | Purity Not Available
Adooq Bioscience
Palifosfamide is a synthetic mustard compound with potential antineoplastic activity.
More Information Supplier PagePalifosfamide 5mg 5mg | Purity Not Available
Adooq Bioscience
Palifosfamide is a synthetic mustard compound with potential antineoplastic activity.
More Information Supplier PagePalifosfamide 25mg 25mg | Purity Not Available
Adooq Bioscience
Palifosfamide is a synthetic mustard compound with potential antineoplastic activity.
More Information Supplier Page